These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37377442)

  • 1. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
    Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
    mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 ORF6 protein targets TRIM25 for proteasomal degradation to diminish K63-linked RIG-I ubiquitination and type-I interferon induction.
    Khatun O; Sharma M; Narayan R; Tripathi S
    Cell Mol Life Sci; 2023 Nov; 80(12):364. PubMed ID: 37982908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
    J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarbecovirus ORF6 proteins hamper induction of interferon signaling.
    Kimura I; Konno Y; Uriu K; Hopfensperger K; Sauter D; Nakagawa S; Sato K
    Cell Rep; 2021 Mar; 34(13):108916. PubMed ID: 33765414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evasion of Type I Interferon by SARS-CoV-2.
    Xia H; Cao Z; Xie X; Zhang X; Chen JY; Wang H; Menachery VD; Rajsbaum R; Shi PY
    Cell Rep; 2020 Oct; 33(1):108234. PubMed ID: 32979938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoupling SARS-CoV-2 ORF6 localization and interferon antagonism.
    Wong HT; Cheung V; Salamango DJ
    J Cell Sci; 2022 Mar; 135(6):. PubMed ID: 35187564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
    Miorin L; Kehrer T; Sanchez-Aparicio MT; Zhang K; Cohen P; Patel RS; Cupic A; Makio T; Mei M; Moreno E; Danziger O; White KM; Rathnasinghe R; Uccellini M; Gao S; Aydillo T; Mena I; Yin X; Martin-Sancho L; Krogan NJ; Chanda SK; Schotsaert M; Wozniak RW; Ren Y; Rosenberg BR; Fontoura BMA; García-Sastre A
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28344-28354. PubMed ID: 33097660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
    Kehrer T; Cupic A; Ye C; Yildiz S; Bouhaddou M; Crossland NA; Barrall EA; Cohen P; Tseng A; Çağatay T; Rathnasinghe R; Flores D; Jangra S; Alam F; Mena I; Aslam S; Saqi A; Rutkowska M; Ummadi MR; Pisanelli G; Richardson RB; Veit EC; Fabius JM; Soucheray M; Polacco BJ; Ak B; Marin A; Evans MJ; Swaney DL; Gonzalez-Reiche AS; Sordillo EM; van Bakel H; Simon V; Zuliani-Alvarez L; Fontoura BMA; Rosenberg BR; Krogan NJ; Martinez-Sobrido L; García-Sastre A; Miorin L
    Cell Host Microbe; 2023 Oct; 31(10):1668-1684.e12. PubMed ID: 37738983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics.
    Schroeder S; Pott F; Niemeyer D; Veith T; Richter A; Muth D; Goffinet C; Müller MA; Drosten C
    Lancet Microbe; 2021 May; 2(5):e210-e218. PubMed ID: 33969329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
    Shemesh M; Aktepe TE; Deerain JM; McAuley JL; Audsley MD; David CT; Purcell DFJ; Urin V; Hartmann R; Moseley GW; Mackenzie JM; Schreiber G; Harari D
    PLoS Pathog; 2021 Aug; 17(8):e1009800. PubMed ID: 34437657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism.
    Huang SH; Lee TY; Lin YJ; Wan L; Lai CH; Lin CW
    J Microbiol Immunol Infect; 2017 Jun; 50(3):277-285. PubMed ID: 26320399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and evasion of type I interferon responses by SARS-CoV-2.
    Lei X; Dong X; Ma R; Wang W; Xiao X; Tian Z; Wang C; Wang Y; Li L; Ren L; Guo F; Zhao Z; Zhou Z; Xiang Z; Wang J
    Nat Commun; 2020 Jul; 11(1):3810. PubMed ID: 32733001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.
    Li JY; Liao CH; Wang Q; Tan YJ; Luo R; Qiu Y; Ge XY
    Virus Res; 2020 Sep; 286():198074. PubMed ID: 32589897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells.
    Zhang Y; Gargan S; Roche FM; Frieman M; Stevenson NJ
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion.
    Gori Savellini G; Anichini G; Gandolfo C; Cusi MG
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98.
    Addetia A; Lieberman NAP; Phung Q; Hsiang TY; Xie H; Roychoudhury P; Shrestha L; Loprieno MA; Huang ML; Gale M; Jerome KR; Greninger AL
    mBio; 2021 Apr; 12(2):. PubMed ID: 33849972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of HDAC2 with SARS-CoV-2 NSP5 and IRF3 Is Not Required for NSP5-Mediated Inhibition of Type I Interferon Signaling Pathway.
    Naik NG; Lee SC; Veronese BHS; Ma Z; Toth Z
    Microbiol Spectr; 2022 Oct; 10(5):e0232222. PubMed ID: 36173315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway.
    Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J
    mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteins.
    Lu Y; Michel HA; Wang PH; Smith GL
    Front Microbiol; 2022; 13():1027015. PubMed ID: 36478862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.